Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 4 |
GO:0005737 | cytoplasm | 2 | 4 |
GO:0043226 | organelle | 2 | 4 |
GO:0043227 | membrane-bounded organelle | 3 | 4 |
GO:0043229 | intracellular organelle | 3 | 4 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 4 |
GO:0110165 | cellular anatomical entity | 1 | 4 |
Related structures:
AlphaFold database: A4IBH4
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 106 | 108 | PF00675 | 0.463 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.442 |
CLV_NRD_NRD_1 | 17 | 19 | PF00675 | 0.424 |
CLV_NRD_NRD_1 | 23 | 25 | PF00675 | 0.473 |
CLV_NRD_NRD_1 | 5 | 7 | PF00675 | 0.448 |
CLV_PCSK_KEX2_1 | 111 | 113 | PF00082 | 0.440 |
CLV_PCSK_KEX2_1 | 135 | 137 | PF00082 | 0.391 |
CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.418 |
CLV_PCSK_KEX2_1 | 23 | 25 | PF00082 | 0.466 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.610 |
CLV_PCSK_PC1ET2_1 | 111 | 113 | PF00082 | 0.424 |
CLV_PCSK_PC1ET2_1 | 135 | 137 | PF00082 | 0.391 |
CLV_PCSK_PC1ET2_1 | 14 | 16 | PF00082 | 0.418 |
CLV_PCSK_PC1ET2_1 | 23 | 25 | PF00082 | 0.435 |
CLV_PCSK_PC1ET2_1 | 84 | 86 | PF00082 | 0.610 |
CLV_PCSK_PC7_1 | 107 | 113 | PF00082 | 0.440 |
CLV_PCSK_SKI1_1 | 103 | 107 | PF00082 | 0.507 |
CLV_PCSK_SKI1_1 | 108 | 112 | PF00082 | 0.474 |
CLV_PCSK_SKI1_1 | 136 | 140 | PF00082 | 0.438 |
CLV_PCSK_SKI1_1 | 6 | 10 | PF00082 | 0.447 |
DOC_MAPK_gen_1 | 134 | 140 | PF00069 | 0.429 |
DOC_MAPK_gen_1 | 84 | 95 | PF00069 | 0.482 |
DOC_PP2B_LxvP_1 | 95 | 98 | PF13499 | 0.482 |
DOC_USP7_UBL2_3 | 111 | 115 | PF12436 | 0.495 |
DOC_USP7_UBL2_3 | 130 | 134 | PF12436 | 0.396 |
DOC_USP7_UBL2_3 | 135 | 139 | PF12436 | 0.395 |
DOC_USP7_UBL2_3 | 19 | 23 | PF12436 | 0.416 |
DOC_USP7_UBL2_3 | 3 | 7 | PF12436 | 0.468 |
DOC_USP7_UBL2_3 | 9 | 13 | PF12436 | 0.473 |
LIG_14-3-3_CanoR_1 | 18 | 22 | PF00244 | 0.432 |
LIG_FHA_1 | 77 | 83 | PF00498 | 0.505 |
MOD_GlcNHglycan | 69 | 72 | PF01048 | 0.728 |
MOD_GSK3_1 | 34 | 41 | PF00069 | 0.478 |
MOD_N-GLC_1 | 123 | 128 | PF02516 | 0.402 |
MOD_PIKK_1 | 38 | 44 | PF00454 | 0.629 |
MOD_PKA_2 | 17 | 23 | PF00069 | 0.430 |
MOD_PKA_2 | 34 | 40 | PF00069 | 0.528 |
MOD_Plk_1 | 123 | 129 | PF00069 | 0.404 |
TRG_NLS_Bipartite_1 | 84 | 105 | PF00514 | 0.508 |
TRG_NLS_MonoExtN_4 | 3 | 10 | PF00514 | 0.480 |
TRG_NLS_MonoExtN_4 | 98 | 105 | PF00514 | 0.510 |
TRG_Pf-PMV_PEXEL_1 | 6 | 10 | PF00026 | 0.462 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I1S0 | Leptomonas seymouri | 77% | 100% |
A0A0S4JBT2 | Bodo saltans | 44% | 92% |
A0A1X0P5F8 | Trypanosomatidae | 56% | 95% |
A0A3Q8IIF2 | Leishmania donovani | 99% | 100% |
A0A3R7MVM6 | Trypanosoma rangeli | 55% | 100% |
A4HMV3 | Leishmania braziliensis | 80% | 100% |
C9ZZ68 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 52% | 100% |
E9AFB0 | Leishmania major | 93% | 100% |
E9B6G5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |